Explore
Companies
Investors
Top 50
Streams
Trending tech news
Latest investments
Latest acquisitions
About Index
Index
By TNW
Log in
Register
Satter Investment Management
0
Satter Investment Management
Suggest edits
Overview
News
Investments
3
Portfolio
Portfolio Tracker
Add info
Pulse 2.0
Akebia Therapeutics (AKBA) Stock: $7 Price Target And Buy Rating
Pulse 2.0
Aerie Pharmaceuticals (AERI) Stock: Why It Substantially Increased
Pulse 2.0
Aerie Pharmaceuticals Stock (AERI): Why The Price Fell Today
Xconomy
On Heels of $100M Financing, Annexon Bio Aims to Tack On More Via IPO
neurons.AI
On Heels of $100M Financing, Annexon Bio Aims to Tack On More Via IPO
$75,000,000
Venture capital (Series C)
PE HUB
Annexon Biosciences takes in $75 mln Series C
$40,000,000
Undisclosed
PE HUB
Aerio Pharmaceuticals takes in about $40 mln
Funding
Messaging
$125,000,000
Post-IPO equity
businesswire
Aerie Pharmaceuticals Raises $125 Million in Public Offerings | Business Wire
$44,000,000
Venture capital (Series B)
FinSMEs
Biopharmaceutical Company Annexon Biosciences Closes $44M Series B Funding
Funding
Health
Science
The Motley Fool
Why Safety Data Is Sending Aerie Pharmaceuticals Soaring Today
Stock markets
The Motley Fool
Why Epizyme Inc, Akebia Therapeutics Inc, and Cempra Inc Got Wacked Today --
Stock markets
Health
Costs
The Motley Fool
Why Akebia Therapeutics Shares Soared 10% Today --
